MALARIA: President's Malaria Initiative

	Dec 14, 2012

New 2013 Malaria Operational Plans  FY 2013 Malaria Operational Plans (MOPs) for PMI are now available on the PMI website. Each of the 20 plans reviews the current status of malaria control and prevention, identifies challenges to meeting PMI goals, and describes planned activities for FY 2013.  Access the FY 2013 MOPs. New PMI Expansion Project in the Democratic Republic of the Congo The new Democratic Republic of the Congo (DRC) PMI Expansion Project (PMI-EP) was recently awarded. The purpose of the PMI-EP is to assist the Government of the DRC to achieve the target of reducing malaria-associated mortality by 50 percent compared to pre-PMI levels by further expanding and scaling up malaria control interventions and reaching new geographic zones.  Read the full announcement and learn more about the project. PMI Data Now Added to the Insecticide Resistance Mapper The Insecticide Resistance (IR) Mapper is a tool used to view results from insecticide resistance studies (WHO susceptibility tests) using mosquitoes collected from sites throughout the world. Data from 18 of the PMI focus countries were recently added to the tool’s database.  View IR Mapper to learn more about what it is and how to use it. New Malaria Diagnosis and Treatment Project Awarded: MalariaCare MalariaCare is a new centrally funded diagnosis and treatment project that supports the expansion of high-quality diagnosis and treatment for malaria and other childhood illnesses and infectious diseases. The project’s services, which include expertise in laboratory strengthening; malaria diagnosis and treatment; and community-based management of sick children, are available to all PMI countries. During the coming year, MalariaCare will begin operating in the DRC, Ethiopia, Ghana, Guinea, Liberia, Malawi, and Zambia.  Learn more about the project’s objectives and approach. Affordable Medicines Facility – Malaria and PMI's Commitment to Global Efforts to Ensure Prompt Malaria Diagnosis and Treatment PMI is committed to ensuring that all persons with malaria are promptly diagnosed and treated with a safe and efficacious antimalarial drug. In sub-Saharan Africa, children under 5 in impoverished, rural areas are at the greatest risk of dying from malaria and are the focus of PMI’s efforts. Subsequent to the Global Fund to Fight AIDS, Tuberculosis and Malaria Board decision in November to integrate the Affordable Medicines Facility – Malaria (AMFm) into core Global Fund grant management and financial processes, PMI remains engaged in supporting AMFm pilot countries through the transition as they incorporate support for scaling up appropriate case management in both the public and private sectors into their Global Fund grants.  Read the full statement on AMFm and PMI's Principles on Scaling Up Malaria Case Management in the Private Sector. Read the news release about the Global Fund Board’s approval to integrate AMFm into core grant processes. Read more PMI News. RSS Feed on PMI.gov Stay up-to-date on what’s new at PMI.gov by subscribing to our RSS feed.  Country Activities     A malaria microscopist examines blood smears in a health center in Oromia Region, Ethiopia. Source: Joe Malone/PMI Voices from the Field – A Focus on Ethiopia Read these new success stories to get a field perspective of how PMI supports key malaria prevention and treatment strategies in Ethiopia. Enriching Communication: The Malaria Research Network of Ethiopia Malaria is a major public health problem in Ethiopia. Seventy-five percent of the more than 80 million inhabitants there are at risk for malaria epidemics. Although significant progress has been observed in scaling up malaria control interventions over the past few years, limited efforts have been invested in using research results to inform national malaria policy and the implementation of malaria control. Learn more about what is being done to improve this process. Read the full story. Improving Malaria Microscopy through Quality Assurance Unlike in other sub-Saharan African countries, malaria in Ethiopia is caused by two malaria parasite species:Plasmodium falciparum (60 percent) and P. vivax (40 percent). Each requires a different curative drug. To ensure that patients are appropriately treated with the correct drug, it is important that patients first receive quality parasitological diagnosis.  Read the full story. Using Micro-planning to Accurately Quantify Needs for Antimalarial Commodities Accurately quantifying antimalarial commodity requirements in Ethiopia is a challenge for multiple reasons. At the district level, poor quantification has often resulted in either an oversupply of antimalarial drugs and diagnostic kits and their subsequent expiry or shortages and stockouts of these commodities. Learn more about using micro-planning to help quantify needs.  Read the full story. Explore more Voices from the Field. New and Updated Resources NetWork’s Online Training Module on NetCALC Now Available NetCALC, a new Excel-based modeling tool, is designed to model scenarios of continuous long-lasting insecticide-treated net distribution approaches based on country-specific data. It provides estimations of the ability of different channels to reach universal coverage. These channels include antenatal, immunization, and curative care clinics; schools; the community; and the retail sector.  Learn more about the training module and how to use NetCALC. Africa Indoor Residual Spraying Program Website Now Live With the goals of limiting exposure to malaria and reducing incidence and prevalence of malaria, Abt Associates, through the Africa Indoor Residual Spraying (AIRS) Program, provides support and leads the implementation of indoor residual spraying activities in up to 17 PMI countries in sub-Saharan Africa.  Learn more about what AIRS does, where it works, and program results on its new website. Updated Funding Tables for FY 2012 Malaria Operational Plans  Download the updated funding tables for the following FY 2012 MOPs: Benin, Ghana, Greater Mekong Subregion, Liberia, Madagascar, Mali, Mozambique, Nigeria, Senegal, and Tanzania.